| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 75241 |
Amino-PEG2-CH2CO2-t-butyl ester，氨基-聚乙二醇2-乙酸叔丁酯 |
160 |
wyh |
2024-12-24 |
| 75242 |
HO-PEG45-CH2CH2COOtBu的介绍 |
113 |
zyl |
2024-12-24 |
| 75243 |
蓝萼甲素脂质体，Glaucocalyxin A Liposome |
114 |
axc |
2024-12-24 |
| 75244 |
Phe-Lys(Trt)-PAB，1116085-99-4，ADC试剂 |
120 |
hyy |
2024-12-24 |
| 75245 |
榄香烯脂质体，Elemene Liposome |
222 |
axc |
2024-12-24 |
| 75246 |
mPEG45-OH 甲氧基四十五聚乙二醇-羟基 |
141 |
zyl |
2024-12-24 |
| 75247 |
Amino-PEG8-t-butyl ester，氨基-聚乙二醇8-乙酸叔丁酯 |
93 |
wyh |
2024-12-24 |
| 75248 |
盐酸柔红霉素脂质体，Hydrochloric Daunorubicin Liposome |
222 |
axc |
2024-12-24 |
| 75249 |
整合素DOTA-E-[cyclo(RGDfK(Acp))]2 |
194 |
zyl |
2024-12-24 |
| 75250 |
Biotin-SS-Py，N-[2-(2-吡啶二硫代)乙基]生物素酰胺 |
143 |
wyh |
2024-12-24 |
| 75251 |
4-Ketobenzotriazine-CH2-S-(CH2)2-COOH,CAS号：170033-08-6 |
189 |
h |
2024-12-24 |
| 75252 |
七肽DOTA-VLASSAR,CAS号:1262403-90-6 |
109 |
zyl |
2024-12-24 |
| 75253 |
多西他赛脂质体，Duoxitasai Liposome |
253 |
axc |
2024-12-24 |
| 75254 |
t-Boc-N-Amido-PEG5-CH2CO2-NHS ester的性质与功能，2743668-40-6 |
107 |
wyh |
2024-12-24 |
| 75255 |
4-Ketobenzotriazine-CH2-S-(CH2)5-COOH,CAS号：221334-33-4 |
176 |
h |
2024-12-24 |
| 75256 |
Fmoc-PEG3-C2-NHS ester,CAS号：1352827-47-4 |
95 |
h |
2024-12-24 |
| 75257 |
DOTA-TATE,CAS:177943-89-4, DOTA-3-酪氨酰基-奥曲肽 |
152 |
zyl |
2024-12-24 |
| 75258 |
Stearic acid-PEG-CH2CO2H, MW 2000 |
101 |
h |
2024-12-24 |
| 75259 |
FmocNH-PEG2-CH2CO2-NHS ester的结构特点，1194666-63-1 |
162 |
wyh |
2024-12-24 |
| 75260 |
Thalidomide-NH-CH2-COOH,CAS号：927670-97-1 |
126 |
h |
2024-12-24 |
| 75261 |
盐酸氨溴索脂质体,Ambroxol Hydrochloride Liposome |
102 |
axc |
2024-12-24 |
| 75262 |
Stearic acid-PEG-CH2CO2H (MW 3400) |
102 |
h |
2024-12-24 |
| 75263 |
CEP1347-VHL-02 |
128 |
h |
2024-12-24 |
| 75264 |
DOTA-GA(tBu)4 cas306776-79-4 大环配体化合物 |
216 |
zyl |
2024-12-24 |
| 75265 |
Z-NH-(CH2)8-NH2·HCl ； N1-叔苄氧羰基-1，8-二氨基辛烷盐酸盐 |
133 |
wyh |
2024-12-24 |
| 75266 |
Stearic acid-PEG-CH2CO2H (MW 5000) |
158 |
h |
2024-12-24 |
| 75267 |
Curcumin Liposome,姜黄素脂质体 |
391 |
axc |
2024-12-24 |
| 75268 |
Stearic acid-PEG-CH2CO2H (MW 1000) |
108 |
h |
2024-12-24 |
| 75269 |
SJF-1528 hemihydrate |
110 |
h |
2024-12-24 |
| 75270 |
Azido-PEG1-CH2CO2H的应用领域，79598-48-4 |
156 |
wyh |
2024-12-24 |
| 75271 |
Ac-Pro-Leu-Val-Glu(OMe)-CH2F |
116 |
h |
2024-12-24 |
| 75272 |
乳酸左氧氟沙星脂质体,Levofloxacin Lactate Liposome |
107 |
axc |
2024-12-24 |
| 75273 |
Azido-PEG1-CH2CO2-NHS的化学结构，2144777-77-3 |
107 |
wyh |
2024-12-24 |
| 75274 |
Tos-PEG1-O-CH2COOH具体解释和潜在应用 |
138 |
h |
2024-12-24 |
| 75275 |
Fmoc-NH-PEG2-CH2COOH,CAS号：166108-71-0,[2-[2-(Fmoc-氨基)乙氧基]乙氧基]乙酸 |
99 |
h |
2024-12-24 |
| 75276 |
Val-cit-PAB-OH，抗体- 药物偶联物，159857-79-1 |
94 |
hyy |
2024-12-24 |
| 75277 |
THP-PEG4-Pyrrolidine(N-Me)-CH2OH,CAS号：2378261-81-3 |
108 |
h |
2024-12-24 |
| 75278 |
Azido-PEG1-CH2CO2-NHS的应用领域，cas:2144777-77-3 |
126 |
wyh |
2024-12-24 |
| 75279 |
THP-PEG4-Pyrrolidine(N-Boc)-CH2OH,CAS号：2378261-80-2 |
104 |
h |
2024-12-24 |
| 75280 |
PEG3-O-CH2COOH,CAS号：51951-05-4,三聚乙二醇-乙酸 |
109 |
h |
2024-12-24 |
| 75281 |
Fmoc-NH-PEG3-amide-CH2OCH2COOH,CAS号：489427-26-1 |
90 |
h |
2024-12-24 |
| 75282 |
Levofloxacin Lactate Liposome,乳酸左氧氟沙星脂质体 |
124 |
axc |
2024-12-24 |
| 75283 |
PROTAC STAT3 degrader-3 |
110 |
h |
2024-12-24 |
| 75284 |
三氧杂十一碳二酸，Azido-PEG5-CH2CO2-PFP |
123 |
wyh |
2024-12-24 |
| 75285 |
Me-triacetyl-β-D-glucopyranuronate-Ph-CH2OH-Fmoc,CAS号：894096-02-7 |
94 |
h |
2024-12-24 |
齐岳微信公众号
官方微信
库存查询